For research use only. Not for therapeutic Use.
BMS-986325 (anti-CD40) is a CD40 inhibitor, and can be used for primary Sjögren’s syndrome research[1].
BMS-986325 (1 and 10 mg/kg, i.v., mice)shows low total serum clearance of 0.5 to 1.02 mL/d/kg, limited volume of distribution at steady state“Vss” of 0.12 to 0.19 L/kg, and long apparent elimination half-life of 118 to 183 hours[1].
| Catalog Number | I040030 |
| Purity | ≥95% |
| Reference | [1]. Aaron YAMNIUKA, et al. ntagonistic cd40 monoclonal antibodies and uses thereof. Patent. WO2020106620A1 |
.gif)